ETFsBloomberg 2027 Maturity USD Corporate Bond Screened Index
Invesco

Invesco BulletShares 2027 USD Corporate Bond UCITS ETF GBP Hdg Dist

B27G LSEIrelandNot PEA-eligible
Last close · EUR
6.41EUR
+0.07% · +€0.00
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
B27GBase
Fund charges
0.12%PRIIPs ongoing costs
Fund size
€15.6Mall share classes
Return 1Y
+9.6%
Sharpe 3Y
Not published
Volatility 1Y
3.0%annualised
Holdings
527Fund holdings

Performance

Compare
  • B27G+9.6%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
B27G+2.2%+3.8%+5.5%+7.6%+9.6%--
MSCI World-2.8%-0.6%+7.8%+14.3%+14.1%+65.6%+64.8%
Gap to MSCI World+5.0%+4.4%-2.3%-6.7%-4.5%--

Risk and return

Sharpe ratio · 1Y
2.31
Above MSCI World · 1.28
Return p.a.
+9.5%
Volatility
3.0%
Max loss
-1.4%Feb 2026

Sharpe vs indices

B27G
2.31
MSCI World
1.28
S&P 500
1.16
STOXX Europe 600
0.99
MSCI Emerging Markets IMI
0.76
CAC 40
-0.01
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
6.6%
Holdings
527
As of
Fund holdings
  1. 1Citigroup Inc 4.45% 29/09/27US172967KA870.86%
  2. 2T-Mobile USA Inc 3.75% 15/04/27US87264ABD630.83%
  3. 3Microsoft Corp 3.3% 06/02/27US594918BY930.80%
  4. 4Amazon.com Inc 3.15% 22/08/27US023135BC960.77%
  5. 5Morgan Stanley 3.625% 20/01/27US61746BEF940.63%
  6. 6Oracle Corp 2.8% 01/04/27US68389XBU810.57%
  7. 7Goldman Sachs Group Inc/The 3.85% 26/01/27US38141GWB660.55%
  8. 8Meta Platforms Inc 3.5% 15/08/27US30303M8G020.54%
  9. 9AbbVie Inc 4.8% 15/03/27US00287YDR710.52%
  10. 10Bank of America Corp 4.183% 25/11/27US06051GGC780.52%

Countries

Not published · Country classification unavailable

Market cap

Weight vs holdings

6.6%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.